ꢁꢀꢀꢀ
ꢂ3
S.Y. Danylchenko et al.: 1-Methyl[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-onesꢂ
+
LC/MS: m/z 399.3 [M+H ] (64%). Anal. Calcd for C22H18N6O2: C, 66.32;
7.80 (dd, J ꢀ=ꢀ 7.8 Hz, J ꢀ=ꢀ 2.0 Hz, 1H), 7.88 (d, J ꢀ=ꢀ 7.8 Hz, 2H), 7.95 (d,
J ꢀ=ꢀ 2.0 Hz, 1H), 8.02 (d, J ꢀ=ꢀ 7.8 Hz, 1H), 8.55 (t, J ꢀ=ꢀ 7.0 Hz, 1H, CONH),
13.10 (s, 1H, NH); 13C NMR: δ 22.7, 25.1, 38.4, 41.2, 118.7, 123.9, 125.0,
126.3, 128.3, 129.2, 130.3, 139.0, 139.6, 146.3, 153.6, 166.8, 169.9. Anal.
Calcd for C20H21N3O2S: C, 65.37; H, 5.76; N, 11.44. Found: C, 65.43; H,
5.74; N, 11.48.
H, 4.55; N, 21.09. Found: C, 66.39; H, 4.52; N, 21.16.
1-Methyl-N-(3-methylbutyl)-5-oxo-4-phenyl-4,5-dihydro[1,2,4]
triazolo[4,3-a]quinazoline-8-carboxamide (7): Protocol AꢁThe
suspension of 2-hydrazino-N-(3-methylbutyl)-4-oxo-3-phenyl-3,4-di-
hydroquinazoline-7-carboxamide 4 (1.83 g, 5 mmol) in acetylacetone
(20 mL) was heated at 100ºC with stirring for 5 h. Afer cooling, the
mixture was diluted with isopropanol (50 mL). The resultant precipi-
tate was filtered, washed with isopropanol (10 mL), and crystallized
from a mixture of DMF (10 mL) and isopropanol (20 mL): yield 1.29 g
(68%), a white solid; mpꢀ>ꢀ300°C; 1H NMR: δ 0.88 (d, J ꢀ=ꢀ 7.0 Hz, 6H),
1.40 (q, J ꢀ=ꢀ 7.0 Hz, 2H), 1.52–1.72 (m, 1H), 2.36 (s, 3H, CH3-1), 3.25 (q,
J ꢀ=ꢀ 7.0 Hz, 2H), 7.42–7.56 (m, 5H), 7.74 (dd, J ꢀ=ꢀ 7.8 Hz, J ꢀ=ꢀ 2.0 Hz, 1H),
8.00 (d, J ꢀ=ꢀ 2.0 Hz, 1H), 8.26 (d, J ꢀ=ꢀ 7.8 Hz, 1H), 8.55 (t, J ꢀ=ꢀ 7.0 Hz, 1H,
CONH); 13C NMR: δ 13.4, 22.7, 25.1, 38.36, 4.2, 118.6, 123.4, 125.8, 126.9,
128.3, 129.1, 130.7, 135.4, 139.0, 139.9, 144.2, 155.5, 161.6, 166.9; LC/MS:
2-Hydrazino-N-(3-methylbutyl)-4-oxo-3-phenyl-3,4-dihydro-
quinazoline-7-carboxamide (4)ꢀA mixture of dioxane (10 mL),
hydrazine hydrate (3 mL), and N-(3-methylbutyl)-4-oxo-3-phenyl-
2-thioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide (3, 1.84 g,
5 mmol) was heated under reflux with stirring for 3 h. The lower
dioxane layer was separated and diluted with water (20 mL). The
precipitate was filtered, washed with isopropanol (10 mL), and
crystallized from mixture of DMF (10 mL) and isopropanol (20 mL):
1
yield 1.29 g (68%); a white solid; mpꢀ>ꢀ300°C (dec.); H NMR: δ 0.88
(d, J ꢀ=ꢀ 7.0 Hz, 6H), 1.40 (q, J ꢀ=ꢀ 7.0 Hz, 2H), 1.52–1.72 (m, 1H), 3.25 (q,
J ꢀ=ꢀ 7.0 Hz, 2H), 5.70 (s, 2H, NHNH2-2), 7.06 (t, J ꢀ=ꢀ 7.8 Hz, 1H), 7.33 (t,
J ꢀ=ꢀ 7.8 Hz, 2H), 7.57 (dd, J ꢀ=ꢀ 7.8 Hz, J ꢀ=ꢀ 2.0 Hz, 1H), 7.75 (d, J ꢀ=ꢀ 2.0
Hz, 1H), 7.88 (d, J ꢀ=ꢀ 7.8 Hz, 2H), 7.98 (d, J ꢀ=ꢀ 7.8 Hz, 1H), 8.55 (t, J ꢀ=ꢀ
7.0 Hz, 1H, CONH), 9.33 (s, 1H, NHNH2-2); 13C NMR: δ 22.7, 25.0, 38.4,
41.2, 118.8, 123.9, 125.6, 126.8, 128.4, 129.1, 130.0, 139.1, 139.7, 146.1,
154.1, 159.2, 166.8. Anal. Calcd for C20H23N5O2 : 65.73; H, 6.34; N, 19.16.
Found: C, 65.79; H, 6.31; N, 19.21.
+
m/z 390.4 [M+H ] (62%). Anal. Calcd for C22H23N5O2: C, 67.85; H, 5.95;
N, 17.98. Found: C, 67.78; H, 5.99; N, 18.03.
Protocol BꢁA solution of 8-[(3,5-dimethyl-1H-pyrazol-1-yl)carbonyl]-
1-methyl-4-phenyl[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one (6, 0.80 g,
2 mmol) and 2-methylbutylamine (0.26 g, 3 mmol) in anhydrous DMF
(10 mL) was heated under reflux for 8 h. Afer cooling, the mixture
was diluted with water (30 mL) and the resultant precipitate was
filtered, washed with isopropanol (10 mL), and crystallized from a
mixture of DMF (5 mL) and isopropanol (10 mL): yield 0.64 g (84%);
a white solid; mpꢀ>ꢀ300°C (dec.). This sample was identical to the
2-Hydrazino-4-oxo-3-phenyl-3,4-dihydroquinazoline-7-carbo-
hydrazide (5)ꢀA mixture of dioxane (10 mL), hydrazine hydrate
(4 mL), and methyl 4-oxo-3-phenyl-2-thioxo-1,2,3,4-tetrahydroquina-
zoline-7-carboxylate (1, 1.56 g, 5 mmol) was heated and stirred under
reflux for 3 h. The lower dioxane layer was separated and diluted with
water (20 mL). The resultant precipitate was filtered, washed with
isopropanol (10 mL), and crystallized from a mixture of DMF (10 mL)
and isopropanol (20 mL): yield 1.21 g (78%); a white solid; mpꢀ>ꢀ300°C
1
sample obtained by protocol A both by H NMR spectrum and LC/
MS data.
1
(dec.); H NMR: δ 4.55 (br. s, 2H, CONHNH2), 5.70 (s, 2H, NHNH2-2),
References
7.08 (t, J ꢀ=ꢀ 7.8 Hz, 1H), 7.33 (t, J ꢀ=ꢀ 7.8 Hz, 2H), 7.57 (dd, J ꢀ=ꢀ 7.8 Hz, J ꢀ=ꢀ
2.0 Hz, 1H), 7.75 (d, J ꢀ=ꢀ 2.0 Hz, 1H), 7.88 (d, J ꢀ=ꢀ 7.8 Hz, 2H), 8.00 (d, J ꢀ=ꢀ
7.8 Hz, 1H), 9.40 (s, 1H, NHNH2-2), 10.02 (s, 1H, CONHNH2); 13C NMR: [1] Elguero, J. Pyrazoles. In Comprehensive Heterocyclic Chemistry II;
δ 118.6, 123.4, 125.7, 126.9, 128.3, 129.1, 130.4, 139.1, 140.0, 144.2, 155.5,
161.7, 166.0. Anal. Calcd for C15H14N6O2: C, 58.06; H, 4.55; N, 27.08.
Found: C, 57.97; H, 4.58; N, 27.13.
Katritzky, A. R.; Rees, C. W.; Scriven, E. F., Eds. Pergamon Press:
Oxford, 1996; Vol. 3, pp. 1–75.
[2] Alvarez-Builla, J.; Vaquero, J. J.; Barluenga, J. Modern Heterocyclic
Chemistry; Wiley-VCH: Weinheim, 2011; Vol. 1, p. 659.
8-[(3,5-Dimethyl-1H-pyrazol-1-yl)carbonyl]-1-methyl-4-phe- [3] Shiho, D.; Tagami, S. Studies on compounds related to
nyl[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one(6)ꢀThesuspension
of 2-hydrazino-4-oxo-3-phenyl-3,4-dihydroquinazoline-7-carbohy-
drazide 5 (1.55 g, 5 mmol) in acetylacetone (20 mL) was heated at
pyrazine. II. The reaction of 3-substituted-2-hydrazinoqui-
noxalines with carbonyl compounds. J. Am. Chem. Soc. 1960,
82, 4044–4054.
100ºC with stirring for 5 h. Afer cooling, the mixture was diluted with [4] Aggarwal, R.; Sumran, G.; Kumar, R.; Singh, Sh. P. Reaction of
isopropanol (50 mL). The resultant precipitate was filtered, washed
with isopropanol (10 mL), and crystallized from a mixture of DMF (10
2-hydrazino-3-methylquinoxaline with aryl-1,3-diketones: a
structural reinvestigation. ARKIVOC 2007, 15, 292–302.
mL) and isopropanol (20 mL): yield 1.47 g (74%); a creamy solid; mp [5] Danilchenko, S. Yu.; Drushlyak, O. G.; Kovalenko, S. M.
296–298°C; 1H NMR: δ 2.12 (s, 3H), 2.36 (s, 3H, CH3-1), 2.55 (s, 3H), 6.26
(s, 1H), 7.52–7.76 (m, 6H), 8.00 (d, J ꢀ=ꢀ 2.0 Hz, 1H), 8.31 (d, J ꢀ=ꢀ 7.8 Hz,
1H); 13C NMR: δ 12.6, 13.3, 14.1, 113.6, 118.8, 123.5, 125.8, 126.9, 128.3,
129.2, 130.8, 135.3, 139.0, 139.9, 141.8, 144.3, 152.3, 155.3, 161.5, 166.1;
Synthesis of substituted 2-hydrazinoquinazolin-4-ones as
intermediates for heterocyclic compounds synthesis. J. Org.
Pharm. Chem. 2014, 12, 66–73 [Zhurn. Org. Pharm. Chim.
2014, 12(3), 66–73].
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 7/25/15 7:34 PM